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Summary Mechanisms of resistance to the active metabolite 5-(3-methyl-1-triazeno)imidazole-4-carboxamide
(MTIC) of the drug 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC) were studied in three human
cell lines with differing amounts of the repair enzyme 06-alkylguanine-DNA alkyltransferase (06AT). The
lines were HT29 (Mer+Rem+), A549 (Mer+Rem-) and VA13 (Mer-). The ability to repair 06 methyl-
guanine was directly related to resistance to MTIC (HT29 ID50 650pmol -1, A549 ID50 210pmol - 1, VA13
ID50 15pmol -1). MTIC produced DNA single strand breaks over the range of one log of cell kill, but
depletion of cellular NAD levels could not be detected until there was greater than 95% cell kill. Inhibitors of
the repair enzyme adenosine diphosphoribosyl transferase (ADPRT) potentiated killing by 2-fold in the Mer+
cell lines but not the Mer- line. The enhancement was directly proportional to an increase in DNA strand
breaks but not a change in their half-life. Therefore resistance to the clinically used methylating agent MTIC
can be partly overcome by inhibiting ADPRT but a role for ADPRT as a suicide mechanism in response to
alkylating agent damage is unlikely.
One of the few active drugs in the treatment of malignant
melanoma (Comis, 1976) and a component of sarcoma
treatment regimens (Gottlieb et al., 1976) is the substituted
triazene 5-(3,3-dimethyl- 1-triazeno)imidazole-4-carboxamide
(DTIC). The mechanism of action is thought to involve
metabolic N-demethylation to give the cytotoxic monomethyl
triazene 5-(3-methyl-I-triazeno)imizadole-4-carboxamide
(MTIC), which can methylate N-7 sites of guanine in DNA
(Preussman & von Hodenburg, 1970).
Because de novo or secondary resistance to DTIC is a
common problem, we have investigated the mechanisms of
resistance to killing and ways to potentiate cytotoxicity in
human tumour cell lines.
Alkylation of DNA at the 06 position of guanine may be
a particularly important lesion in determining cellular
sensitivity to methylating agents (Erickson et al., 1980).
Human tumour cells which possess the suicide repair enzyme
06-alkylguanine-DNA alkyltransferase (O6AT) can remove
06 alkyl lesions by an error-free repair mechanism and are
much more resistant to methylating agents than cells
deficient in this enzyme (Harris et al., 1983). Cell lines
capable of supporting the growth of N-methyl-N'-nitro-
N-nitrosoguanidine (MNNG) damaged adenovirus are also
resistant to MNNG cytotoxicity, possess O6AT and are
defined as having the Mer+ phenotype (Scudiero et al.,
1984). Mer- tumour strains are unable to repair 06 methyl-
guanine (06MeG) lesions in DNA. An intermediate group of
Mer+ cell lines, although able to support the growth of
MNNG-treated adenovirus, have an intermediate sensitivity
to the cytotoxicity of MNNG and are designated Rem-
(Scudiero et al., 1984).
The Mer phenotypes also correlate with sensitivity to
crosslinking nitrosoureas such as 1,3-bis(2-chloroethyl)-l-
nitrosourea (BCNU) and 1-(2-chloroethyl)-1-nitrosourea
(CNU) and the methylating agent methyl methanesulphonate
(MMS). DNA crosslinking by chloroethylnitrosoureas is
believed to involve the initial formation of a monoadduct at
the 06-position of guanine residues. Removal of this
monoadduct by 06AT prevents crosslink formation
(Erickson et al., 1980).
MTIC has recently been shown to alkylate DNA in the
guanine-06 position in vivo (Meer et al., 1986), so we have
compared the sensitivity of cell lines with the three different
Mer phenotypes.
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Methylating agents also interact with another component
of DNA repair- poly ADP-ribose polymerase, or adenosine
diphosphoribosyl transferase (ADPRT) (Durkacz et al.,
1980). This enzyme is absolutely dependent on DNA strand
breaks for activity and catalyses the conversion of nicotin-
amide adenine dinucleotide (NAD) to poly ADP-ribose,
which covalently modifies numerous nuclear proteins
(Creissen & Shall, 1982). Inhibition of ADPRT activity with
nicotinamide analogues, such as 3-aminobenzamide (3AB),
potentiates the killing effects of several methylating agents,
and it has been postulated that this is due to the regulation
of DNA ligases by ADPRT. Strand breaks are induced by
the repair and spontaneous loss of methylated bases in
DNA, and these breaks accumulate in the presence of
ADPRT inhibitors. The depletion of NAD in synthesizing
poly ADP-ribose has been postulated to lead to a drop in
ATP levels and hence cell death (Sims et al., 1983).
A more potent nicotinamide analogue is 3-acetamido-
benzamide (3AAB) (Purnell & Whish, 1980). We have
therefore compared the potentiating effects of 3AAB on cell
lines with differing sensitivities to MTIC to try and
overcome resistance and related the effects to strand breaks
and NAD levels.
Materials and methods
Cell culture
HT29 (human colon carcinoma) cells were were obtained
from the American Type Culture Collection (ATCC HTB-
38). A549 (human lung adenocarcinoma) cells were kindly
supplied by Dr Adi Gazdar, NCI, Bethesda, Maryland,
USA. W138-VA13 (SV40-transformed W138 human
fibroblast) cells were obtained from Flow Laboratories Ltd.,
Rickmansworth, Herts, WD3 1PQ.
Cells were grown as monolayers in either Roswell Park
Memorial Institute Medium 1640 (A549 cells) or Eagle's
Minimum Essential Medium (HT29 and VA13 cells). Both
media were supplemented with 10% (v/v) foetal bovine
serum, penicillin (100IUml-1), streptomycin (100pgml-1)
and nystatin (50IUml-1). EMEM was further supplemented
with non-essential amino acids (0.1 mmol 1 1)
Drugs
MTIC was synthesized by preparing the diazo derivative
(DZC) of 5-aminoimidazole-4-carboxamide (AICA) and
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reacting this with methylamine in dimethyl sulphoxide
(DMSO). Product purity was established by NMR
spectroscopy. A full description of the synthesis will be
published separately (Bleasdale et al., in preparation). MTIC
was stored protected from light at -20°C. Because of its
short half-life in aqueous solutions, MTIC was dissolved in
DMSO immediately before use at 200 times the desired final
concentrations and added to cell cultures.
3AAB was synthesized by reacting 3AB with acetic
anhydride (Purnell & Whish, 1980).
Cell survival assay
Assays were carried out in triplicate. Cells (-30 x 103) were
seeded into 6-well culture dishes 1-2 days before use. Culture
medium was replaced just before the addition of solutions of
MTIC in DMSO. After 30min at 37°C, medium containing
or omitting 3AAB was replaced and cells were grown for
about three doublings. Cells were harvested by trypsinization
and counted using a Coulter ZM counter. Cell survival was
assessed by the increase in number of cells, expressed as a
percentage of the mean value for cultures not receiving
MTIC.
DNA strand break assay
An alkaline unwinding procedure was used to measure DNA
strand breaks (Cavanaugh et al., 1984). Cells were grown in
100 x 15mm tissue culture dishes to give --5 x 106 cells/dish.
At appropriate times after addition of MTIC, growth
medium was aspirated, the cell layer was rinsed with ice-cold
PBS and the cells were harvested using a cell scraper
(Costar). The number of DNA strand breaks was calculated
per alkaline unwinding unit (Cavanaugh et al., 1984).
NAD assay
Cellular NAD levels were measured using the procedure of
Nisselbaum and Green(1969). Adherent cell cultures were
exposed to MTIC, and NAD levels were measured after 2h
(Skidmore et al., 1979). No change of growth medium was
necessary during this time, since no active drug remained
after 15min in culture medium (Parsons et al., 1982, and our
own unpublished findings). Cell layers were rinsed with ice-
cold PBS and harvested in 50% aqueous ethanol using a cell
scraper (Costar). Cell suspensions were disrupted by
sonication (MSE Soniprep 150) and centrifuged (MSE
Microfuge). The supernatant solutions were assayed for
NAD.
Results
MTIC cytotoxicity in Mer+, Mer+Rem-, Mer- cell lines
Cell survival was measured in HT29 (Mer+Remn), A549
(Mer+Rem-) and VA13 (Mer-) cell lines. The results from
representative experiments are shown in Figures 1, 2 and 3.
The sensitivity was inversely proportional to the ability to
remove 06 methylguanine, with doses producing 50%
toxicity (ID50) of 650+ 140Mmoll-1, 210+40iimoll1- and
15+4jumoll-1 for HT29, A549 and VA13 cells respectively.
Since MTIC is rapidly hydrolysed to AICA, which, when
ribosylated (AICAR), could have an effect on purine
precursor pools, the effect of AICAR was assessed and
found to be non-cytotoxic at equimolar concentrations to
MTIC (Figure 2).
Potentiation ofMTIC by 3AAB
3AAB potentiated cell killing by a dose enhancement factor
of 2 at 50% survival in both Mer+ cell lines. At MTIC doses
producing 1% survival in the presence of 3AAB in both cell
lines, there was approximately 30% survival in the absence
of 3AAB.
In contrast, there was no potentiating effect of 3AAB on
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Figure 1 Effect of 3AAB on the cytotoxity of MTIC:HT29
cells. The effect on cell proliferation of each concentration of
drug was measured in triplicate cultures. Mean values+s.d. are
shown. 0 MTIC alone, 0 MTIC+ 1 mmol1- I 3AAB.
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Figure 2 Effect of 3AAB on the cytotoxicity of MTIC:A549
cells. The effect on cell proliferation of each concentration of
drug was measured in triplicate cultures. Mean values+s.d. are
shown. 0 MTIC alone, 0 MTIC+1 mmol1- I 3AAB, A
AICAR.
the Mer- cell line until less than 50% survival was obtained.
At low survival, there was a potentiating effect consisting
of a 4-fold difference in survival at 50pmoll-1 MTIC (3%
with 3AAB, 11% without 3AAB).
Relation ofDNA strand breaks to cell killing andpotentiation
by 3AAB
DNA strand breaks were assayed over the range of MTIC
concentrations associated with up to approximately one
lethal hit per cell (D37) in the Mer+ cell line A549. This
range is likely to be relevant to in vivo use of the drug where
only a 1-2 log cell kill can be achieved in responding
tumours.
The assay was linear up to 500 4umol11 MTIC, but
extensive fragmentation beyond 600jumol 1 1 prevented
quantitation of strand breaks at high MTIC concentrations
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Figure 3 Effect of 3AAB on the cytotoxicity of MTIC:VA13
cells. The effect on cell proliferation of each concentration of
drug was measured in triplicate cultures. Mean values+s.d. are
shown. 0 MTIC alone, 0 MTIC+1 mmol1-1 3AAB.
(Figure 4). Thus, over the range of concentrations likely to
be relevant in vivo, there was a linear relationship between
strand breaks and MTIC concentration.
It has been hypothesized that inhibitors of ADPRT
enhance the action of cytotoxic drugs by interfering with
DNA repair (Shall, 1982). Therefore, DNA strand breaks
were measured in A549 cells exposed to 100jimol 1 - MTIC
in the absence or presence of 3AAB (Figure 5). The time
course of appearance of strand breaks in the absence of
3AAB was rapid and they disappeared in a biphasic manner,
with an initial half-life of 50min.
In the presence of 3AAB there was a doubling of the peak
number of strand breaks detected, but their rate of dis-
appearance was not decreased. The initial half-life of
disappearance was 45 min.
Thus, the dose enhancement factor was proportional to
the increase in peak number of strand breaks, not a change
in half-life.
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Figure 5 DNA strand breaks produced in A549 cells by MTIC.
Appearance and removal of DNA strand breaks following
exposure of cells to MTIC (100jimol 11) in the absence (0) or
presence (0) of 3AAB (1 mmoll-1).
EiJects ofMTIC on NAD levels
Since the activation of ADPRT, caused by the appearance of
DNA strand breaks, would result in the utilization of NAD
for the synthesis of poly ADP-ribose, the dose-related effects
of MTIC on NAD levels were assessed. MTIC produced a
marked lowering in NAD levels in A549 cells linearly related
to dose (Figure 6). However, this decrease was over the
concentration range 1-5 mmol I- and did not occur below
1 mmoll- MTIC, a concentration associated with >95%
cell killing.
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Figure 4 DNA strand breaks produced in A549 cells by MTIC.
DNA strand breaks produced by 30min exposure to a range of
concentrations of MTIC were assessed in triplicate cultures.
Mean values are shown.
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Figure 6 Effect of MTIC on NAD levels in A549 cells. NAD
was measured in triplicate cultures 2h after exposure to a range
ofconcentrations of MTIC. Mean values+s.d. are shown.
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Discussion
MTIC produced differential effects on cell lines with the
different Mer phenotypes. The proportional sensitivity of the
three lines to MTIC (Mer+ 1, Mer+Rem- 0.3, Mer- 0.02)
is very similar to that reported for MNNG (Mer+ 1,
Mer+Rem- 0.26, Mer- 0.03) (Scudiero et al., 1984). It is
apparent that variations in the Mer+ phenotype (Rem- or
Rem') are associated with differences in sensitivity to
MTIC. This is potentially important clinically, because the
Mer- phenotype has not been convincingly demonstrated in
primary human tumours. Although approximately 30% of
cell lines studied are Mer-, in studies of human normal and
tumour material directly, absence of O6AT is much rarer
(Waldstein et al., 1982; Myrnes et al., 1984a,b; Gerson et al.,
1985; Wiestler et al., 1984; Umbenhauer et al., 1985;
Grafstrom et al., 1984; Wani et al., 1985). In none of the
series is absence reported, out of over 150 patient samples.
Also, SV40 transformation of Mer+ cell lines can produce
the Mer- phenotype (Day et al., 1980).
Therefore attempts to potentiate cell killing in Mer+ cell
lines are much more important for therapeutic applications.
Potentiation of MTIC toxicity by 3AAB was similar with
cells of both Mer+ phenotypes. Since O6MeG is not
removed from DNA by excision repair (Olsson & Lindahl,
1980), this suggests that it is the production of AP sites, and
hence DNA strand breaks, during excision repair of other
bases that is important in killing Mer+ cell lines and that the
level of these breaks is increased in the presence of 3AAB.
These experiments were all carried out in a concentration
range of drugs relevant to the proportional cell kill obtained
in vivo with chemotherapy. In this cytotoxic drug range there
were two observations at conflict with some current assess-
ments of the interaction of ADPRT with inhibitors and
DNA repair.
Although 3AAB doubled the amount of strand breaks at
100pmoll- 1 MTIC and produced a 2-fold dose
enhancement effect, there was no change in the rate of repair
of breaks. Since one major explanation of the effect of
3AAB is that DNA ligase II is not activated for DNA repair
when ADPRT is inhibited (Creissen & Shall, 1982), one
would expect a decreased rate of repair. Recently, Walker et
al. (1984) and Cleaver and Morgan (1985) showed that more
repair patches result from DNA damage in the presence of
3AB, rather than longer patches that would occur if ligation
was decreased. Similarly, Moran and Ebisuzaki (1985) found
that 3AB produced an increase in strand breaks but no
change in rejoining rate. Our results with MTIC are
compatible with the postulate that inhibitors of ADPRT
allow the action of an endonuclease on damaged DNA,
producing more breaks but not changing patch size of rate
of ligation.
The other proposed mechanism relating increased cell
killing to the use of ADPRT inhibitors involves prevention
of NAD depletion. NAD depletion does occur in methyl-
ating agent treated cells, and can ultimately lead to a
decrease in intracellular ATP levels. It has been postulated
that this is a suicide mechanism for badly damaged cells and
that ATP depletion may allow repair to occur, but not
replication (Wintersberger & Wintersberger, 1985; Carson et
al., 1986; Sims et al., 1985). Stopping the NAD drop by
inhibiting ADPRT would maintain ATP levels and allow
replication on a damaged template, hence potentiating the
effects of DNA damage.
Although we showed that MTIC, similarly to other
methylating agents, did produce a NAD drop, this only
occurred at very high MTIC levels (>1 mmolI-). Thus the
postulated mechanism of action of ADPRT inhibitors is
unlikely to be relevant in vivo.
Parsons et al. (1982) and Hayward and Parsons (1984a)
produced a human melanoma cell line that was resistant to
MTIC after a single high dose exposure. They found that the
resistant line was able to remove 06 methylguanine lesions
from its DNA or prevent their formation, much more
rapidly than the parent sensitive line. Gibson et al. (1986)
reported the effects of MTIC on HT29, IMR90, VA13 and
BE cell lines. The former two are Mer+, the latter two
Mer-. They found equal amounts of DNA strand breaks in
the Mer+ and Mer- lines at equimolar doses, but MTIC
was much more toxic to Mer- lines.
Although strand breaks appear linearly related to MTIC
dose, the strand unwinding assay we used and the alkaline
elution reported by Gibson et al. (1986) did not detect
breaks at 25 moll- MTIC, a concentration producing at
least 50% cell kill in Mer- cell lines. Thus, the failure of
3AAB to potentiate MTIC toxicity in the Mer- cell line
implies that strand breaks or hypersensitivity to strand
breaks is not a major mechanism of cell killing at low MTIC
concentrations. Hayward and Parsons (1984b) also found
that an MTIC sensitive melanoma cell line was potentiated
far less by another ADPRT inhibitor, 3-aminobenzamide,
than the parent resistant line. The use of 3AAB can
therefore indicate the relative contributions of different types
of DNA damage to cell killing at different MTIC
concentrations.
Although the results above suggest the O6MeG lesion in
DNA produced by MTIC is a killing lesion, Karran and
Williams (1985) found that depleting cells of 06AT with the
free methylated base 06MeG did not potentiate the
cytotoxicity of nitrosoureas. The lack of potentiation of
Mer- cell lines with 3AAB at low MTIC doses suggests that
there may be yet another type of lethal lesion in Mer- cell
lines at low drug concentrations besides 06MeG and strand
breaks in DNA, or that very low residual amounts of 06AT
are effective. Tisdale, using a novel triazene precursor, found
a delayed elevation of ADPRT activity at 2 days in a cell
line capable of differentiation. This was probably related to
cell cycle effects rather than immediate DNA damage
(Tisdale, 1985). The observation that 06MeG is produced
in cellular DNA by MTIC and that MTIC can be
potentiated by 3AAB provides the basis for in vivo studies to
potentiate crosslinking nitrosoureas by competing for
O6MeG repair, and to potentiate MTIC in Mer+ cells with
DNA repair inhibitors. The recent development of pre-
cursors to MTIC that are more easily activated than DTIC
(Stevens et al., 1984; Wilman et al., 1984; Rutty et al., 1984)
will enable this approach to be assessed clinically.
We thank Professor B.T. Golding for synthesis of MTIC. This work
was supported by the North of England Cancer Research
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